Compositions and methods for inhibition of HIV-1 infection

Details for Australian Patent Application No. 2001290925 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Olson, William C.; Maddon, Paul J.

Agent Davies Collison Cave

Pub. Number AU-B-2001290925

PCT Pub. Number WO02/22077

Priority 60266738 06.02.01 US; 09912824 25.07.01 US; US01/02633 26.01.01 WO; 09663219 15.09.00 US

Filing date 14 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 13 July 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 July 2006 Application Accepted

  Published as AU-B-2001290925

9 November 2006 Standard Patent Sealed

14 August 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Nov 2006. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000 2002

22 January 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Nov 2006 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001290926-Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof

2001290924